CI Society

Vision

To cure Primary Immunodeficiency (PI).

back to top

Mission

Our mission is to improve the lives of people with Primary Immune (PI) by promoting early diagnosis and effective treatments and through leadership in research, education and advocacy in partnership with healthcare professionals, volunteers, industry and government.

back to top

Our Values

These serve as our guidelines as we work in implementing our Vision:

• Equal access to all Canadians

• Dignity and respect for all individuals – We believe that all people should be treated with consideration. We appreciate diversity

• Accountability – We are committed to using donors’ dollars wisely

• Commitment to communities – We will nurture effective partnerships with volunteers, staff and other organizations

• Optimism –We believe that any challenges can be overcome with hope and determination

back to top

How We Help

CI Society 2010

For 2010, 67% of every donated dollar was spent on programs and services. Reports within Canada Revenue Agency indicate this is better than most charities.

back to top

History

The Society was founded in 1999 by John Perl, whose child was diagnosed with severe combined immunodeficiency (SCID), Jay Lefton, philanthropist and partner at Aird & Berlis, and Dr. Chaim Roifman, Division Chief of Immunology/Allergy at the Hospital for Sick Children in Toronto, Canada. The CI Society plays a vital role in being one of the first organizations in Canada to support research in the field of primary immunodeficiency as well as supporting education of patients and medical professionals.

Board Members:

John F. Perl, President
Chaim Roifman, MD, FRCPC, Chair & Scientific Director
Peter Clark
Thomas Moran
Barry Reichmann
Joseph Vital

Chief Executive Officer:

Richard Thompson, CFRE

Corporate Advisory Board:

“The Canadian Immunodeficiency Society is the most important organization in Canada for the community of physicians and patients addressing Primary Immunodeficiencies. We applaud their significant accomplishments in education, awareness, advocacy and patient support.” – Vicki and Fred Modell, Jeffrey Modell Foundation, New York, USA.

Joel Abelson, Vice President, Canada and Intercontinental Business, Talecris Biotherapeutics
Vicki Modell, Co-founder, Jeffrey Modell Foundation
Paul R. Perreault Sr., President, CSL Behring

back to top